Sanofi: After Novo Nordisk, Sanofi also enters the seasonal bull market!

Sanofi is one of the largest pharmaceutical companies in the world, covering a wide range of prescription medications, vaccines, and specialty therapies. The company is particularly strong in the development of drugs for rare diseases, autoimmune disorders, and diabetes. In addition to its established portfolio, Sanofi is increasingly focusing on biopharmaceutical innovations and expanding in the mRNA technology sector. Through strategic acquisitions and partnerships, especially in immunology, the company secures long-term growth and strengthens...